Back to results
US 2023/0147101 A1Published application
Treatment of Chemosensory Dysfunction from a Coronavirus Infection
AssigneeCyrano Therapeutics, Inc.
InventorsRichard GEOFFRION, Robert I. HENKIN
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of treating a taste and smell disorder caused by a viral infection in a subject, comprising administering to the subject a phosphodiesterase inhibitor. Also disclosed herein are methods of treating taste and smell loss from COVID-19 by administering a phosphodiesterase inhibitor to a subject in need thereof.
Claims32
A method for treating chemosensory dysfunction in a human, wherein the chemosensory dysfunction is at least in part produced from, or occurring during or after, a coronavirus infection, the method comprising:
- administering to the human a therapeutically effective amount of a phosphodiesterase (PDE) inhibitor or a pharmaceutically acceptable salt thereof to treat the chemosensory dysfunction, wherein
- (i) the coronavirus comprises SARS-CoV-2 or a mutated form thereof,
- (ii) the PDE inhibitor or pharmaceutically acceptable salt thereof is administered in a formulation in unit dose form;
- or
- (iii) any combination thereof.
2 more elements
Dependencies are inferred from the claim text.